Chilling. It isn’t often that a bit of news is a perfect fit to that one-word description, but the recent decision by a Los Angeles jury in the first case to be decided pitting Johnson & Johnson (J&J; New Brunswick,…
Category Archives: Orthopedics
Gigantic jury award in first J&J hip implant case is breathtaking as an initial benchmark
March 13, 2013 – 2:00 PM
SpinalCyte solution could shape biologics future
November 30, 2012 – 5:07 PM
Recently, I had the opportunity to interview Pete O’Heeron, CEO of a private company called SpinalCyte, a company developing an application to treat degenerative disc disease using cells derived from human skin for the Nov. 9th edition of Medical Device…
Could Medtronic eventually shed Infuse?
September 26, 2011 – 6:00 AM
After Johnson & Johnson (J&J, New Brunswick, New Jersey) said that it was going to discontinue its work in the drug eluting stent (DES) market, my eyes then began to focus on Medtronic (Minneapolis), which has recently taken a beating…
Is Medtronic’s cancellation of GPO contracts a prelude to a trend, or just an anomaly?
March 21, 2011 – 12:27 PM
Late last month, Medtronic (Minneapolis) reported that it was cancelling several of its largest contracts with group purchasing organizations (GPOs) worth more than $2 billion collectively. Medtronic said the decision to cancel five contracts with Novation (Irving, Texas) and another…
